Roche's Big China Play
Roche's big China play -------- RocheandGenentechare always on the hunt for deals, and they found their newest partner out of China. Rocheponied up $60 million upfrontto get its hands on a prostate cancer drug candidate fromJemincare, promising up to $590 million in biobucks, plus royalties, down the line for the androgen receptor degrader. After spending years developing commercial and manufacturing ops along with a biotech incubator in Shanghai, Roche BD chiefJames Sabrysays this new, first-time pactsignals more alliances ahead in China after watching the Asian biotech industry develop into a force to be reckoned with.